Healthpeak Properties (NYSE:DOC) Issues FY24 Earnings Guidance

Healthpeak Properties (NYSE:DOC) issued an update on its FY24 earnings guidance on Thursday morning. The company provided EPS guidance of $1.79-1.81 for the period, compared to the consensus EPS estimate of $1.79. Healthpeak Properties also updated its FY 2024 guidance to 1.560-1.580 EPS.

Healthpeak Properties Stock Performance

NYSE DOC traded down $0.71 on Friday, hitting $22.29. 8,802,307 shares of the company’s stock traded hands, compared to its average volume of 4,002,954. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.91. Healthpeak Properties has a 1-year low of $15.24 and a 1-year high of $23.26. The firm’s 50-day moving average price is $22.26 and its two-hundred day moving average price is $20.66. The firm has a market capitalization of $15.59 billion, a PE ratio of 47.43, a P/E/G ratio of 3.30 and a beta of 1.14.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings data on Thursday, July 25th. The real estate investment trust reported $0.21 EPS for the quarter, missing the consensus estimate of $0.44 by ($0.23). Healthpeak Properties had a net margin of 11.93% and a return on equity of 3.51%. The business had revenue of $695.50 million for the quarter, compared to analyst estimates of $665.11 million. During the same quarter in the previous year, the firm posted $0.45 earnings per share. The business’s revenue was up 27.5% on a year-over-year basis. As a group, analysts expect that Healthpeak Properties will post 1.79 EPS for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Monday, November 4th will be paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 5.38%. The ex-dividend date is Monday, November 4th. Healthpeak Properties’s payout ratio is 255.32%.

Analyst Ratings Changes

DOC has been the subject of several recent research reports. Citigroup lifted their target price on shares of Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd. Royal Bank of Canada lifted their target price on shares of Healthpeak Properties from $22.00 to $25.00 and gave the company an “outperform” rating in a report on Tuesday, July 30th. StockNews.com lowered shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Saturday, October 19th. Deutsche Bank Aktiengesellschaft raised shares of Healthpeak Properties from a “hold” rating to a “buy” rating and lifted their target price for the company from $20.00 to $28.00 in a report on Monday, October 21st. Finally, Scotiabank lifted their target price on shares of Healthpeak Properties from $23.00 to $24.00 and gave the company a “sector outperform” rating in a report on Monday, September 9th. One analyst has rated the stock with a sell rating, five have issued a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $22.62.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.